by Lisa Willemse | Feb 22, 2019
Please click here to read the original version of the article that first appeared on Medicine by Design’s site and is reprinted with permission. The article has been edited slightly for length. A contagious facial cancer that has ravaged Tasmanian devils in southern...
by Camila Londono | Oct 31, 2016
Though the last day of the Till and McCulloch Meetings was a short one, it was absolutely fantastic. The day began with a thought-provoking talk by Douglas Sipp, from the Riken Center for Developmental Biology, touching upon the many issues surrounding regulation of...
by Paul Krzyzanowski | May 21, 2015
. By now, many of you will have heard of Fujifilm’s USD$307 million purchase of Cellullar Dynamics International (CDI). This may seem like a major entry into the regenerative medicine (RM) space for a company that’s better known for its imaging technologies than...
by David Kent | Mar 18, 2015
Earlier this month, Harvard Medical School researchers published a brief report in Cell Stem Cell, which showed in non-human primates – in this case monkeys – that Parkinson’s disease symptoms could be alleviated using stem cell therapy. Using induced pluripotent stem...
by Lisa Willemse | Jul 14, 2014
Written with contributions from Geoff Lomax, CIRM’s Senior Officer for Medical and Ethical Standards and Rosario Isasi, Research Associate at McGill University and Academic Secretary for the International Stem Cell Forum Ethics Working Party. Portions of this post...
Comments